@Article{biocell.2021.014621, AUTHOR = {YASHVI SHARMA, SUCHI GUPTA, SUJATA MOHANTY}, TITLE = {Mesenchymal stem cell-derived exosome as a nano weapon to target the COVID-19 pandemic}, JOURNAL = {BIOCELL}, VOLUME = {45}, YEAR = {2021}, NUMBER = {3}, PAGES = {517--520}, URL = {http://www.techscience.com/biocell/v45n3/41695}, ISSN = {1667-5746}, ABSTRACT = {In these times of despair when a nano-sized organism, the SARS-CoV-2, has rendered the human race helpless, made the global health status decline, and drowned the world economy, a ray of hope comes from another nano-sized particle, the exosome. The potential of mesenchymal stem cells has already been established in COVID-19; however, cell-based therapy has its risks. We thereby propose cell-free therapy using stem cells-derived exosomes to fight against COVID-19, as they can be a game-changer owing to their immunomodulatory nature, which combats the cytokine storm characterizing this disease, and their practical efficiency, which will realistically aid large access to therapy worldwide.}, DOI = {10.32604/biocell.2021.014621} }